Exicure, Inc.

NasdaqCM:XCUR

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 48.58 M

Share Price

USD 7.69

Avg Daily Volume

112,827

Change (1 day)

3.92%

Change (1 year)

141.82%

Change (YTD)

-43.74%

Exicure, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending August 08, 2025: N/A

Exicure, Inc. Operating Cash Flow is NA for the Trailing 12 Months (TTM) ending August 08, 2025. Operating cash flow is cash generated from the company’s regular business operations.

Competitors

Eli Lilly and Company

USD 746.37

LLY

-19.58 -2.56%

AbbVie Inc.

USD 196.30

ABBV

-2.25 -1.13%

Roche Holding AG

USD 322.52

RO.SW

-10.06 -3.03%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novartis AG

USD 114.49

NOVN.SW

-3.72 -3.15%

Novo Nordisk A/S

USD 45.10

NOVO-B.CO

-2.22 -4.69%

Merck & Co., Inc.

USD 79.44

MRK

-1.35 -1.67%

Thermo Fisher Scientific Inc.

USD 448.94

TMO

-17.48 -3.75%

Amgen Inc.

USD 284.67

AMGN

-15.41 -5.13%

Pfizer Inc.

USD 23.93

PFE

-0.82 -3.31%

Gilead Sciences, Inc.

USD 110.28

GILD

-2.18 -1.94%

Sanofi

USD 92.89

SAN.PA

-2.06 -2.17%

Vertex Pharmaceuticals Incorporated

USD 385.65

VRTX

+10.67 2.84%

Bristol-Myers Squibb Company

USD 44.82

BMY

-1.03 -2.25%

Chugai Pharmaceutical Co., Ltd.

USD 49.92

4519.T

-0.37 -0.73%

View all

Key Data

Date	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities